Corning Incorporated (GLW)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Corning Incorporated (GLW) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011054
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for telecommunications networks; ceramic substrates and filters for mobile emission control systems; and optical bio-sensors used in drug discovery. It also manufactures advanced optics and specialty glass solutions for semiconductor, defense, metrology, aerospace, consumer electronics and other industries. The company operates a network of research centers in North America, Europe and Asia. It operates in the Americas, Europe, Asia-Pacific, the UAE and South Africa. Corning is headquartered in Corning, New York, the US.

Corning Incorporated (GLW) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Corning Incorporated, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Corning Incorporated, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Corning Incorporated, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Corning Incorporated, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Corning Incorporated, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Corning Incorporated, Medical Equipment, Deal Details 10
Asset Purchase 10
Corning Completes Acquisition of Majority Stake In Discovery Labware Unit Of Becton, Dickinson For US$730 Million 10
Venture Financing 12
NinePoint Medical Raises US$34 Million In Series B Financing 12
Partnerships 13
Daylight Solutions Enters Into Licensing Agreement With Corning 13
Debt Offering 14
Corning Raises USD190.23 Million in Public Offering of Senior Notes Due 2024 14
Corning Raises USD90.58 Million in Public Offering of Senior Notes Due 2037 15
Corning Raises USD427.6 Million in Public Offering of Senior Notes Due 2027 16
Corning Completes Public Offering Of Senior Unsecured Notes Due 2037 For US$250 Million 17
Corning Completes Public Offering Of Senior Unsecured Notes Due 2042 For US$500 Million 18
Corning Incorporated – Key Competitors 19
Corning Incorporated – Key Employees 20
Corning Incorporated – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Jul 25, 2017: Corning And Stevanato Group Enter New Agreement To Supply New Corning Valor Glass To The Pharmaceutical Packaging Market 25
Other Significant Developments 26
Jul 24, 2017: Corning and Gerresheimer Collaborate to Deliver New Corning Valor Glass to the Pharmaceutical Packaging Market 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Corning Incorporated, Medical Equipment, Key Facts, 2016 2
Corning Incorporated, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Corning Incorporated, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Corning Incorporated, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Corning Incorporated, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Corning Incorporated, Deals By Market, 2011 to YTD 2017 8
Corning Incorporated, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Corning Completes Acquisition of Majority Stake In Discovery Labware Unit Of Becton, Dickinson For US$730 Million 10
NinePoint Medical Raises US$34 Million In Series B Financing 12
Daylight Solutions Enters Into Licensing Agreement With Corning 13
Corning Raises USD190.23 Million in Public Offering of Senior Notes Due 2024 14
Corning Raises USD90.58 Million in Public Offering of Senior Notes Due 2037 15
Corning Raises USD427.6 Million in Public Offering of Senior Notes Due 2027 16
Corning Completes Public Offering Of Senior Unsecured Notes Due 2037 For US$250 Million 17
Corning Completes Public Offering Of Senior Unsecured Notes Due 2042 For US$500 Million 18
Corning Incorporated, Key Competitors 19
Corning Incorporated, Key Employees 20
Corning Incorporated, Other Locations 21
Corning Incorporated, Subsidiaries 22
Corning Incorporated, Joint Venture 24

★海外企業調査レポート[Corning Incorporated (GLW)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Cooperativa Muratori & Cementisti C.M.C di Ravenna:企業の戦略・SWOT・財務分析
    Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report Summary Cooperativa Muratori & Cementisti C.M.C di Ravenna - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • UNITIKA LTD.:企業の戦略・SWOT・財務情報
    UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report Summary UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Power Machines:企業の戦略的SWOT分析
    Power Machines - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bio-Modeling Systems SAS-製薬・医療分野:企業M&A・提携分析
    Summary Bio-Modeling Systems SAS (BM Systems) is a mechanism based medicine company which discovers and develops novel diagnostic, therapeutic and prevention solutions. The company owns an operational mechanisms-based medicine platform known as Computer-Assisted Deductive Integration (CADI), which i …
  • eHealthInsurance Services Inc:企業の戦略的SWOT分析
    eHealthInsurance Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Strike Energy Ltd (STX):企業の財務・戦略的SWOT分析
    Summary Strike Energy Ltd (Strike Energy) is an oil and gas exploration and development company that explores, produces, and develops shale oil and gas. The company provides properties such as Eagle Ford Shale, Permian Basin, Cooper Basin, gulf coast conventional, and others. It has exploration and …
  • Berli Jucker Public Co Ltd:企業の戦略・SWOT・財務情報
    Berli Jucker Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Berli Jucker Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Anglo American Plc:企業の戦略・SWOT・財務情報
    Anglo American Plc - Strategy, SWOT and Corporate Finance Report Summary Anglo American Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Guangdong Zhongsheng Pharmaceutical Co Ltd (002317):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangdong Zhongsheng Pharmaceutical Co Ltd (Guangdong Zhongsheng Pharma) is a pharmaceutical company that develops, manufactures and supplies Chinese patent medicines, medicinal herbs and chemical medicines. The company offers its products in the form of tablets, capsules, pills, injections, …
  • The Saudi Arabian Monetary Agency:企業の戦略的SWOT分析
    The Saudi Arabian Monetary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Mayo Foundation for Medical Education and Research:企業の戦略的SWOT分析
    Mayo Foundation for Medical Education and Research - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …
  • Greatcell Solar Ltd (GSL)-エネルギー分野:企業M&A・提携分析
    Summary Greatcell Solar Ltd (Greatcell Solar), formerly Dyesol Limited, is a renewable energy company that develops and commercializes Perovskite Solar Cells (PSC) or solid-state dye solar cell (DSC), the third generation photovoltaic technology. The company develops a range of PSC chemicals, compon …
  • eTheRNA Immunotherapies NV:製薬・医療:M&Aディール及び事業提携情報
    Summary ETheRNA Immunotherapies NV (eTheRNA) is a developer of novel immunotherapies for the treatment of cancers and infectious diseases. The company’s pipeline products include mRNA-based immunotherapies for various indications such as melanoma, triple negative breast cancer and infectious disease …
  • NanoCarrier Co Ltd (4571):企業の財務・戦略的SWOT分析
    Summary NanoCarrier Co Ltd (NanoCarrier) is a drug development company that develops and produces pharmaceuticals using micellar nanoparticles technology. The company’s pipeline products include NC-6004, NC-4016, NC-6300, VB-111, NC-6201 and NK105. It offers siRNA micelle, protein micelle, DACH-plat …
  • China Resources Beer (Holdings) Co Ltd:戦略・SWOT・企業財務分析
    China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Resources Beer (Holdings) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Getinge AB (GETI B):企業の財務・戦略的SWOT分析
    Getinge AB (GETI B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Selecta Biosciences Inc (SELB):企業の財務・戦略的SWOT分析
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Thermo Fisher Scientific Inc.:企業の戦略・SWOT・財務情報
    Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report Summary Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆